| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/11/2022 | 104.08% | Guggenheim | $7 → $6 | Maintains | Buy |
| 08/15/2022 | 240.14% | Jefferies | → $10 | Initiates Coverage On | → Buy |
What is the target price for The Oncology Institute (TOI)?
The latest price target for The Oncology Institute (NASDAQ: TOI) was reported by Guggenheim on November 11, 2022. The analyst firm set a price target for $6.00 expecting TOI to rise to within 12 months (a possible 104.08% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for The Oncology Institute (TOI)?
The latest analyst rating for The Oncology Institute (NASDAQ: TOI) was provided by Guggenheim, and The Oncology Institute maintained their buy rating.
When is the next analyst rating going to be posted or updated for The Oncology Institute (TOI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of The Oncology Institute, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for The Oncology Institute was filed on November 11, 2022 so you should expect the next rating to be made available sometime around November 11, 2023.
Is the Analyst Rating The Oncology Institute (TOI) correct?
While ratings are subjective and will change, the latest The Oncology Institute (TOI) rating was a maintained with a price target of $7.00 to $6.00. The current price The Oncology Institute (TOI) is trading at is $2.94, which is out of the analyst's predicted range.